-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Linaclotide for irritable bowel syndrome with constipation: a review
Michael Arriaga & Eamonn MM Quigley
Drug Evaluation: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Glycopyrronium for chronic obstructive pulmonary disease: evidence and rationale for use from the GLOW trials
Marc Miravitlles, Kai-Michael Beeh & Pablo Altman
Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Eliglustat tartrate: an oral therapeutic option for Gaucher disease type 1
Gregory M Pastores and Derralynn Hughes
Review: Clinical Trail Outcomes: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Market authorization granted for Bydureon the first once-weekly medication for Type 2 diabetes
News and Views: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation
-
Clinical trials of systemic therapy in osteosarcoma and Ewing\\\'s sarcoma: past, present and future
R Grant Rowe, Rashmi Chugh
Review Article: Clinical Investigation